Authors

• Shaoyong Peng (ORCID: https://orcid.org/0000-0002-5489-4869)
• Jing Lin (ORCID: https://orcid.org/0000-0002-0203-7419)
• Jun Huang
• Guangjian Liu (ORCID: https://orcid.org/0000-0001-9275-9214)
• Yi Lin (ORCID: https://orcid.org/0000-0002-5919-6074)
• Mingzhe Huang (ORCID: https://orcid.org/0000-0002-8103-9382)
• Meijin Huang (ORCID: https://orcid.org/0000-0002-6530-3104)
• Pinzhu Huang (ORCID: https://orcid.org/0000-0002-8339-9701)
• Si Qin (ORCID: https://orcid.org/0000-0002-0863-9699)
• Zhiliang Chen (ORCID: https://orcid.org/0000-0001-5575-0501)
• Zhiyong Chen (ORCID: https://orcid.org/0000-0001-5032-8280)
• Jiaming Zhou (ORCID: https://orcid.org/0000-0001-9411-0777)
• Yan Huang (ORCID: https://orcid.org/0000-0003-4822-5615)
• Maram Alenzi

Institutions

• Beth Israel Deaconess Medical Center (US)
• Sun Yat-sen University (CN)
• Guangdong Pharmaceutical University (CN)
• Sixth Affiliated Hospital of Sun Yat-sen University (CN)
• Zhongshan People's Hospital (CN)
• Dongguan People’s Hospital (CN)
• Fujian Provincial Hospital (CN)

Publication Details

Journal

BMC Gastroenterology

Published

2024-09-30

DOI

https://doi.org/10.1186/s12876-024-03419-0

Citations

3

Primary Topic

Hepatocellular Carcinoma Treatment and Prognosis

Type

article

Field-Weighted Citation Impact

1.11

Funders

• National Natural Science Foundation of China
• Sun Yat-sen University
• Natural Science Foundation of Fujian Province
• Natural Science Foundation of Guangdong Province
• Fujian Provincial Health Commission
• Project 211
• Fundamental Research Funds for the Central Universities